GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Payments of Debt

HLS Therapeutics (TSX:HLS) Payments of Debt : C$-12.76 Mil (TTM As of Dec. 2023)


View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Payments of Debt?

HLS Therapeutics's Payments of Debt for the three months ended in Dec. 2023 was C$-4.44 Mil.

HLS Therapeutics's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was C$-12.76 Mil.

HLS Therapeutics Payments of Debt Historical Data

The historical data trend for HLS Therapeutics's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Payments of Debt Chart

HLS Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.18 -8.54 -14.26 -14.18 -12.70

HLS Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.47 -3.12 -2.06 -3.15 -4.44

HLS Therapeutics Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-12.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HLS Therapeutics Payments of Debt Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (TSX:HLS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Payments of Debt
Comparable Companies
NEOE:CBST XCNQ:IAN TSX:CRDL XCNQ:JUSH XCNQ:FFNT XCNQ:EPIC TSXV:RX XCNQ:GRIN TSX:CPH XCNQ:PLTH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
HLTRF:USA
Address
10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2
Website
https://www.hlstherapeutics.com
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (TSX:HLS) Headlines

No Headlines